Acute macular neuroretinopathy after Covid 19 in an eye with a congenital retinal macrovessel – a case report

Q3 Medicine

American Journal of Ophthalmology Case Reports Pub Date : 2025-05-06 DOI:10.1016/j.ajoc.2025.102349

A. Vienne-Jumeau , E. Souied , F. Amoroso

{"title":"Acute macular neuroretinopathy after Covid 19 in an eye with a congenital retinal macrovessel – a case report","authors":"A. Vienne-Jumeau , E. Souied , F. Amoroso","doi":"10.1016/j.ajoc.2025.102349","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To present a case of an acute macular neuroretinopathy (AMN) occurring after Covid 19 infection in an eye with a retinal macrovessel.</div></div><div><h3>Observations</h3><div>We report a case of a 48-year-old woman who presented to our center with a 10-day scotoma in her right eye, in the context of a recently diagnosed Covid 19 infection. The funduscopy demonstrated a petaloid brown lesions temporal to the fovea in the right eye. A retinal macrovessel, passing adjacent to the lesions was also present. The left eye was normal. Multimodal imaging confirmed the diagnostic of AMN and optical coherence tomography angiography showed defects in the deep capillary plexus colocalizing with the lesions.</div></div><div><h3>Conclusions and importance</h3><div>Ischemic events have been known to complicate macrovessel, and we reckon that the occurrence of AMN in this patient could have been the resultant of the conjunction of Covid 19 infection and abnormal retinal vasculature.</div></div>","PeriodicalId":7569,"journal":{"name":"American Journal of Ophthalmology Case Reports","volume":"38 ","pages":"Article 102349"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Ophthalmology Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451993625001021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

To present a case of an acute macular neuroretinopathy (AMN) occurring after Covid 19 infection in an eye with a retinal macrovessel.

Observations

We report a case of a 48-year-old woman who presented to our center with a 10-day scotoma in her right eye, in the context of a recently diagnosed Covid 19 infection. The funduscopy demonstrated a petaloid brown lesions temporal to the fovea in the right eye. A retinal macrovessel, passing adjacent to the lesions was also present. The left eye was normal. Multimodal imaging confirmed the diagnostic of AMN and optical coherence tomography angiography showed defects in the deep capillary plexus colocalizing with the lesions.

Conclusions and importance

Ischemic events have been known to complicate macrovessel, and we reckon that the occurrence of AMN in this patient could have been the resultant of the conjunction of Covid 19 infection and abnormal retinal vasculature.

查看原文本刊更多论文

先天性视网膜大血管眼新冠肺炎后急性黄斑神经视网膜病变1例

目的报告1例视网膜大血管感染后发生急性黄斑神经视网膜病变（AMN）的病例。我们报告了一例48岁的女性，她在最近诊断为Covid - 19感染的情况下，右眼出现了10天的暗斑。眼底镜显示右眼颞部至中央窝有花瓣状棕色病变。视网膜大血管，通过病变附近也存在。左眼正常。多模态成像证实了AMN的诊断，光学相干断层血管造影显示与病变共定位的深毛细血管丛缺陷。缺血性事件可使大血管复杂化，我们认为该患者AMN的发生可能是Covid - 19感染和视网膜血管异常共同作用的结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Ophthalmology Case Reports Medicine-Ophthalmology

CiteScore

2.40

自引率

0.00%

发文量

513

审稿时长

16 weeks

期刊介绍： The American Journal of Ophthalmology Case Reports is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished case report manuscripts directed to ophthalmologists and visual science specialists. The cases shall be challenging and stimulating but shall also be presented in an educational format to engage the readers as if they are working alongside with the caring clinician scientists to manage the patients. Submissions shall be clear, concise, and well-documented reports. Brief reports and case series submissions on specific themes are also very welcome.